In the Research Letter titled “Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic,”1 published in the December 15, 2020, issue of JAMA, a programming code error led to incorrect data reported throughout the Results section, the Figure, the Table, and the eTable in the Supplement. The main findings did not change. This article was corrected online.
Reference
- 1.Huskamp HA, Busch AB, Uscher-Pines L, Barnett ML, Riedel L, Mehrotra A. Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA. 2020;324(23):2440-2442. doi: 10.1001/jama.2020.21512 [DOI] [PMC free article] [PubMed] [Google Scholar]